Previous 10 | Next 10 |
home / stock / innpf / innpf news
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Canada NewsWire With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of ...
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 1, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ph...
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval. Canada NewsWire HERZLIYA, Israel and CALGARY, AB , March 25, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (...
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million Canada NewsWire NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY , Alberta ,...
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study Canada NewsWire Innocan Announces Notice of Intention to Complete a Private Placement of Units HERZLIYA, Israel and CALGARY, Alberta...
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Feb. 26, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Compa...
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024 Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , Feb. 20, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), i...
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , Dec. 12, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (th...
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , Nov. 3, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan"...
Innocan Pharma reports a groundbreaking discovery regarding its LPD platform and global CBD research Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , Oct. 23, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company"...
News, Short Squeeze, Breakout and More Instantly...
Innovative Properties Inc Company Name:
INNPF Stock Symbol:
OTCMKTS Market:
Innovative Properties Inc Website:
InnoCan Pharma Corp. (OTCQB:INNPF) (CSE:INNO) (FSE: IP4) an Israel-based cannabinoids-focused pharmaceutical company, announced its interim consoli...
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Canada NewsWire The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pai...